Advertising
Ximelagatran, the first of the alternative agents to be developled, is a direct thrombin inhibitor. It showed clinical efficacy in non-valvular atrial fibrillation and venous thromboembolic disease...
Printed from Australian Family Physician - https://www.racgp.org.au/afp/authorslist/c/jenny-curnow© The Australian College of General Practitioners www.racgp.org.au